Breaking News on Pharmaceutical Technology

Latest news headlines

Products

Suppliers

SkyePharma's controlled release doze gets the nod from Somnus

27-Jun-2007 - SkyePharma's novel controlled-release sleep therapeutic has been licensed by Somnus Therapeutics in an exclusive worldwide development and commercialisation deal.

KV boosts drug delivery abilities

14-Jun-2007 - KV Pharmaceutical has snapped up a specialist coatings firm that it hopes will enhance the company's drug delivery product pipeline.

Prosolv tech in API development pact

12-Jun-2007 - JRS Pharma has entered into a collaboration with US firm CoreRX to develop co-processed active pharmaceutical ingredients (APIs) using JRS's high functionality excipient technology, Prosolv

Active Biotech drug could have the edge in oral MS race

07-Jun-2007 - A joint effort to develop a winning oral formulation for the treatment of multiple sclerosis (MS) has taken another step towards the finish line with initiation of Phase III trials for the novel laquinimod compound.

Malta gives Siegfried the generic advantage

07-Jun-2007 - Siegfried Generics this week kicked off production at its new manufacturing facility in Malta making the most of the country's lack of pharma patents which gives the firm a head-start in producing generic pharmaceuticals.

Million Euro milestone for GSK drug

06-Jun-2007 - An Italian firm specialising in novel drug delivery technologies is due to receive a lump sum of €1m following the successful development of a new formulation of a GlaxoSmithKline (GSK) drug.

Softgel formulation to challenge Abbott drug

31-May-2007 - Two firms have announced a licence and supply agreement for a novel formulation of valproic acid presented as a softgel capsule, which could challenge Abbott's top selling drug Depakote (divalproex sodium).

Symetix launches optical inspection system for solid-dose pharmaceuticals

31-May-2007 - Symetix has launched an optical inspection system for solid-dose pharmaceuticals, with a particular emphasis on softgel capsules.

Parallel trade pushing fakes?

29-May-2007 - Batches of two fake blockbuster drugs are being recalled after counterfeits made their way into the UK supply chain via parallel distribution, adding fuel to the debate on the security of the practice in the EU.

Oral calcitonin into Phase III for osteoarthritis

29-May-2007 - An oral formulation of salmon calcitonin based on Emisphere Technologies' eligen delivery system has entered Phase III clinical trials for the treatment of osteoarthritis.

Once-a-day pharyngitis drug one step closer

23-May-2007 - The US Food and Drug Administration have finally accepted Advancis Pharmaceutical's new drug application (NDA) for its once daily amoxicillin Pulsys product for tonsillitis and pharyngitis.

ACCU-BREAK aims to divide and rule with tabletting tech

23-May-2007 - Novel tabletting technology developed by US company ACCU-BREAK Pharmaceuticals promises to solve the problem of uneven doses when pills are split by hand.

SkyePharma's GeoMatrix underpins another new drug formulation

17-May-2007 - UK company SkyePharma's GeoMatrix technology has been used to develop a new formulation of a hypertension drug which can provide lower drug doses.

Granules India tabletting plant to come onstream in August

16-May-2007 - Contract manufacturer Granules India is moving towards vertical integration, with a new tabletting facility scheduled to come onstream this August at the company's Gagillapur site near Hyderabad in India.

Midatech nanoparticles aiming for the clinic in 2008

14-May-2007 - Midatech, the UK group exploring the therapeutic and diagnostic applications of nanoparticles as drug delivery vehicles, scaffolds for synthetic vaccines or antibiotics and non-invasive imaging agents, is hoping to put its first product into clinical trials in 2008.

BioProgress unveils FastWrap technology for rapid tablet disintegration

03-May-2007 - Specialty pharmaceutical and healthcare company BioProgess has come up with another twist on its tablet coating technology, TabWrap.

New product makes counterfeiting 'virtually impossible'

02-May-2007 - A new machine developed by US firm Vardex Laser promises to offer a unique solution to the global problem of drug counterfeiting, protecting products right down to the pill itself.

Roquette wins US patent for StarLac in novel dosage form

25-Apr-2007 - French company Roquette has been awarded a US patent for a dissolve-in-the-mouth drug delivery technology that makes use of its novel StarLac excipient.

BioProgress nudges into profit with new market-driven profile

23-Apr-2007 - A new market-oriented approach to product development, more favourable licensing arrangements, strategic acquisitions and a fresh crop of proprietary drug-delivery technologies helped UK company BioProgress to deliver an adjusted operating profit for the first time in its history in the year to 31 December 2006.

Skye formulation accepted for GSK drug

16-Apr-2007 - UK firm SkyePharma last week announced that the US Food and Drug Administration (FDA) has accepted a filing for the extended release formulation of partner GlaxoSmithKline's (GSK) drug Requip (ropinirole).

New wheat variety aids fight against blight

21-Mar-2007 - Researchers have created a new strain of wheat with an inbuilt resistance to devastating scab blight which infects wheat heads - reducing crop yields as well as market value and quality.

Fuji gets DMF for fast dissolving excipient

14-Mar-2007 - Japanese firm Fuji Chemical has been assigned a drug master file (DMF) number for its new excipient for fast-dissolving oral tablets.

QuitPak enters pilot study

13-Feb-2007 - A combination therapy to help smokers kick the habit has begun evaluation in Phase I pilot studies in the US. A sustained-release formulation of Cary Pharmaceutical's QuitPak has been developed with IntelGenx Technologies as an alternative smoking cessation therapy.

Legumes encapsulate oral antifungal drug

07-Feb-2007 - US-based drug delivery firm, BioDelivery Sciences International (BDSI), has asked for approval to start clinical trials of a soya bean-based delivery technology that would lead to the first oral version of amphotericin B, a widely-used antifungal drug.

BioProgress taps TabWrap potential

07-Feb-2007 - UK-based firm BioProgress has developed novel tablet cores that mean pills which were previously very difficult to coat can be reformulated and easily coated using the company's innovative TabWrap technology.

Sign up for your free newsletter